MedPath

Lay-user Trial of the iGlucose Blood Glucose Monitoring System

Completed
Conditions
Diabetes Mellitus
Interventions
Device: Blood glucose monitor
Registration Number
NCT02709707
Lead Sponsor
Nina Peled
Brief Summary

Evaluation of the iGlucose Blood Glucose Monitoring System in the hands of lay users

Detailed Description

A non-randomized, prospective study of recruited subjects with diabetes. Subjects will include those with type I or type II diabetes of various duration and those who are naive to self-testing of blood glucose. Subjects will use provided instructions-for-use to undergo self-training on the use of the device and will then self-test their blood glucose level. Results will be compared to those obtained by a lab glucose analyzer.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
153
Inclusion Criteria
  • Be 12 years of age and older
  • Have pre-existing diagnosis of diabetes
  • Be able to read and understand English
  • Agree to participate in the study
  • Be able and willing to provide informed consent
Exclusion Criteria
  • Do not meet Inclusion Criteria
  • With Hemophilia or any other bleeding disorder
  • With any condition which in the opinion of the Investigator may place the subject or site staff at excessive risk
  • With physical condition/limitation preventing the use of SMBG on their own

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with diabetesBlood glucose monitor-
Primary Outcome Measures
NameTimeMethod
Accuracy of blood glucose measurements as performed by lay users10 minutes to produce self blood result and to perform lab comparative method
Secondary Outcome Measures
NameTimeMethod
Assessment by lay users of the ease of use of the iGlucose Blood Glucose Monitoring System2 -3 hours of going through a self-training session and producing an assessment

Trial Locations

Locations (1)

Diablo Clinical Research

🇺🇸

Walnut Creek, California, United States

© Copyright 2025. All Rights Reserved by MedPath